FLT3 and acute myeloid leukemia: Activating mutations of FLT3, including FLT3 internal tandem duplications (FLT-ITD) are among the most common genetic alterations in AML (approximately 30% of the patients), and FLT3-ITD positivity has been associated with increased relapse rate and diminished overall survival [25, 26].